Enlivex Therapeutics (NasdaqCM:ENLV) Q4 2025 Earnings call March 25, 2026 09:00 AM ET Company ParticipantsOren Hershkovitz - CEOShai Novik - Executive ChairmanOperatorType your question in. With us today are Enlivex's Executive Chairman, Shai Novik, and Chief Executive Officer, Oren Hershkovitz. I'd like to start by reminding you that certain comments on this call are forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Please review the forward-looking and cautiona ...